Next Article in Journal
Reversing Cardiac Hypertrophy at the Source Using a Cardiac Targeting Peptide Linked to miRNA106a: Targeting Genes That Cause Cardiac Hypertrophy
Next Article in Special Issue
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People
Previous Article in Journal
Safety and Pharmaceutical Evaluation of a Novel Natural Polymer, Ocicum, as Solubility and Dissolution Enhancer in Solid Dispersion
Previous Article in Special Issue
Use of an Electronic Medication Management Support System in Patients with Polypharmacy in General Practice: A Quantitative Process Evaluation of the AdAM Trial
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(7), 870; https://doi.org/10.3390/ph15070870
Action Date Notes Link
article pdf uploaded. 14 July 2022 17:44 CEST Version of Record https://www.mdpi.com/1424-8247/15/7/870/pdf-vor
article supplementary file uploaded. 14 July 2022 17:44 CEST - https://www.mdpi.com/1424-8247/15/7/870#supplementary
article xml file uploaded 15 July 2022 07:52 CEST Original file -
article xml uploaded. 15 July 2022 07:52 CEST Update -
article pdf uploaded. 15 July 2022 07:52 CEST Updated version of record https://www.mdpi.com/1424-8247/15/7/870/pdf-vor
article html file updated 15 July 2022 07:53 CEST Original file -
article xml file uploaded 25 July 2022 08:55 CEST Update -
article xml uploaded. 25 July 2022 08:55 CEST Update https://www.mdpi.com/1424-8247/15/7/870/xml
article pdf uploaded. 25 July 2022 08:55 CEST Updated version of record https://www.mdpi.com/1424-8247/15/7/870/pdf
article html file updated 25 July 2022 08:56 CEST Update -
article html file updated 13 August 2022 01:51 CEST Update https://www.mdpi.com/1424-8247/15/7/870/html
Back to TopTop